Vilya
Vilya uses AI-driven computational design to generate novel macrocycle drugs for human diseases. Its medicines are designed to combine the target precision of biologics with the convenience of oral dosing, including for diseases that are difficult to treat with existing drugs.
Facts
- HQ
- Seattle, Washington, USA
- Sectors
- Biotechnology, Drug discovery, Artificial intelligence
- Founders
- David Baker, Gaurav Bhardwaj, Lance Stewart, Patrick Salveson, Adam Moyer, Nao Hiranuma
Is this your organization? Claim it
Members see Vilya's funding rounds, amounts and investors.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events